Best Evidence Webinar: Completing the picture: the need for access to regulatory documents for better drug assessment

Dr. Juan Erviti is a qualified hospital pharmacist in Pamplona, Navarra, Spain. His research activity is focused on pharmacoepidemiology and systematic reviews, and has published over 50 articles in high impact medical journals. He is the Director of the Navarre Cochrane Associate Center and a member of the Cochrane Hypertension satellite group in Spain. He is currently leading a RIAT project (Restoring Invisible and Abandoned Trials) to restore a trial on the results of Platelet-Rich Plasma (PRP) for knee injury and has recently completed another RIAT project on the restoration of the FOURIER (evolocumab) trial, published in BMJ Open 2022; 12:e060172.

Dr. Juan Erviti is a qualified hospital pharmacist in Pamplona, Navarra, Spain. His research activity is focused on pharmacoepidemiology and systematic reviews, and has published over 50 articles in high impact medical journals. He is the Director of the Navarre Cochrane Associate Center and a member of the Cochrane Hypertension satellite group in Spain. He is currently leading a RIAT project (Restoring Invisible and Abandoned Trials) to restore a trial on the results of Platelet-Rich Plasma (PRP) for knee injury and has recently completed another RIAT project on the restoration of the FOURIER (evolocumab) trial, published in BMJ Open 2022; 12:e060172.